From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

We concisely review clinical, autopsy, experimental and molecular data of 2019 coronavirus disease (COVID-19). Angiotensin-converting enzyme 2 disruption and thromboinflammatory microangiopathy emerge as distinctive features. Briefly, entry of the virus into microvessels can profoundly disrupt the local renin-angiotensin system, cause endothelial injury, activate the complement cascade and induce powerful thromboinflammatory reactions, involving, in particular, von Willebrand factor, that, if widespread, may lead to microvascular plugging, ischemia and, ultimately, organ failure. We believe the current COVID-19 data consolidate a widely unrecognised paradigm of potentially fatal thromboinflammatory microvascular disease.
Lingua originaleEnglish
pagine (da-a)243-247
Numero di pagine5
RivistaINTERNATIONAL JOURNAL OF CARDIOLOGY
DOI
Stato di pubblicazionePubblicato - 2021

Keywords

  • 2019 coronavirus
  • Complement
  • Renin-angiotensin system
  • Thromboinflammatory microangiopathy
  • von Willebrand factor
  • Thrombosis
  • COVID-19
  • Humans
  • Inflammation Mediators
  • Microvessels
  • Renin-Angiotensin System
  • Angiotensin-Converting Enzyme 2

Fingerprint Entra nei temi di ricerca di 'From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19'. Insieme formano una fingerprint unica.

Cita questo